Hiperlipidemias primarias. Clasificaci?n, diagn?stico y riesgo asociado

2002, Circulation, 106, 3143, 10.1161/circ.106.25.3143 Rubi?s-Prat, 2005, Dislipoproteinemias primarias, 661 Ridker, 2004, Factores de riesgo de la enfermedad ateroescler?tica, 1238 Goldstein, 2001, The cholesterol quartet, Science, 292, 1310, 10.1126/science.1061815 Alonso, 2002, Hipercolesterolemia familiar heterocigota en Espa?a. Estudio descriptivo de 819 casos no relacionados, Med Clin (Barc), 118, 487, 10.1016/S0025-7753(02)72428-7 Kane, 2001, Disorders of the biogenesis and secretion of lipoproteins containing the B apolipoproteins, 2717 1999, Human Genetics Program. Familial hypercholesterolaemia Real, 2001, Identificaci?n y caracterizaci?n del primer espa?ol con defecto homocigoto familiar de uni?n de la liprote?na B, Med Clin (Barc), 116, 138, 10.1016/S0025-7753(01)71750-2 Garc?a, 2001, Autosomal recessive hipercolesterolemia caused by mutations in a putative LDL receptor adaptor protein, Science, 292, 1394, 10.1126/science.1060458 2000 Ribalta, 1997, A varisation in the apolipoprotein C-IIIgene is associated with an increased number of circulating VLDL and IDL particles in familial combined hyperlipidemia, J Lipid Res, 38, 1061, 10.1016/S0022-2275(20)37189-3 Purnell, 2001, Relationship of insulin sensitivity and apo B levels to intra-abdominal fat in subjects with familial combined hyperlipidemia, Arterioscler Thromb Vasc Biol, 21, 567, 10.1161/01.ATV.21.4.567 Brunzell, 2001, Familial lipoprotein lipase deficiency, apo C-II deficiency, and hepatic lipase deficiency, 2789 Talmud, 2001, Genetic determinants of plasma triglycerides: impact of rare and commun mutations, Curr Atheroscler Rep, 3, 191, 10.1007/s11883-001-0061-4 Rubins, 2000, The trouble with triglycerides, Arch Intrn Med, 160, 1903, 10.1001/archinte.160.13.1903 Wittrup, 1999, Lipoprotein lipase mutation, plasma lipid and lipoproteins, and risk of ischemic heart disease. A meta-analysis, Circulation, 99, 2901, 10.1161/01.CIR.99.22.2901 Malhey, 2001, Type III hyperlipoproteinemia (dysbetalipoproteinemia): the role of apolipoprotein apo E in normal and abnormal lipoprotein metabolism, 2835 Civeira, 1996, Apo E variants in patients with type III hyperlipoproteinemia, Atherosclerosis, 127, 273, 10.1016/S0021-9150(96)05969-2 Dugi, 2001, Low hepatic lipase activity is a novel risk factor for coronary artery disease, Circulation, 104, 3057, 10.1161/hc5001.100795 Tall, 2001, Genetic disorders affecting plasma high-density lipoproteins, 2915 Civeira, 2001, Alteraciones del metabolismo de las HDL, Clin Invest Arterioscler, 13, 35 Santamarina-Fojo, 2001, Lecithin cholesterol acyltranferase deficiency and fish eye disease, 2817 Lee, 2001, Genetic basis of sitosterolemia, Curr Opin Lipidol, 12, 141, 10.1097/00041433-200104000-00007